Language selection

Search

Details for: OCTREOTIDE FOR INJECTABLE SUSPENSION

Company: TEVA CANADA LIMITED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02503751OCTREOTIDE FOR INJECTABLE SUSPENSIONOCTREOTIDE (OCTREOTIDE ACETATE)10 MG / VIALKITINTRAMUSCULAR
02503751OCTREOTIDE FOR INJECTABLE SUSPENSIONOCTREOTIDE (OCTREOTIDE ACETATE)10 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02503778OCTREOTIDE FOR INJECTABLE SUSPENSIONOCTREOTIDE (OCTREOTIDE ACETATE)20 MG / VIALKITINTRAMUSCULAR
02503778OCTREOTIDE FOR INJECTABLE SUSPENSIONOCTREOTIDE (OCTREOTIDE ACETATE)20 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02503786OCTREOTIDE FOR INJECTABLE SUSPENSIONOCTREOTIDE (OCTREOTIDE ACETATE)30 MG / VIALKITINTRAMUSCULAR
02503786OCTREOTIDE FOR INJECTABLE SUSPENSIONOCTREOTIDE (OCTREOTIDE ACETATE)30 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: